Benefits of Tebentafusp in Uveal Melanoma Last 3 Years Benefits of Tebentafusp in Uveal Melanoma Last 3 Years

A new analysis suggests that the treatment ' s benefits for overall survival endures for at least 36 months.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news